191 related articles for article (PubMed ID: 27820656)
1. Insulinlike Growth Factor Binding Protein-1 and Ghrelin Predict Health Outcomes Among Older Adults: Cardiovascular Health Study Cohort.
Kaplan RC; Strizich G; Aneke-Nash C; Dominguez-Islas C; Bužková P; Strickler H; Rohan T; Pollak M; Kuller L; Kizer JR; Cappola A; Li CI; Psaty BM; Newman A
J Clin Endocrinol Metab; 2017 Jan; 102(1):267-278. PubMed ID: 27820656
[TBL] [Abstract][Full Text] [Related]
2. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Xue X; Kritchevsky SB; Newman AB; Psaty BM
J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
[TBL] [Abstract][Full Text] [Related]
3. Effect of a high-protein diet on ghrelin, growth hormone, and insulin-like growth factor-I and binding proteins 1 and 3 in subjects with type 2 diabetes mellitus.
Gannon MC; Nuttall FQ
Metabolism; 2011 Sep; 60(9):1300-11. PubMed ID: 21406307
[TBL] [Abstract][Full Text] [Related]
4. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
[TBL] [Abstract][Full Text] [Related]
5. High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly.
Kaplan RC; McGinn AP; Pollak MN; Kuller L; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
Am Heart J; 2008 Jun; 155(6):1006-12. PubMed ID: 18513511
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone, insulinlike growth factor-1, and insulinlike growth factor binding proteins 1 and 3 in chronic liver disease.
Donaghy A; Ross R; Gimson A; Hughes SC; Holly J; Williams R
Hepatology; 1995 Mar; 21(3):680-8. PubMed ID: 7533122
[TBL] [Abstract][Full Text] [Related]
7. Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study.
Hu D; Pawlikowska L; Kanaya A; Hsueh WC; Colbert L; Newman AB; Satterfield S; Rosen C; Cummings SR; Harris TB; Ziv E;
J Am Geriatr Soc; 2009 Jul; 57(7):1213-8. PubMed ID: 19558480
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults.
Zhang WB; Aleksic S; Gao T; Weiss EF; Demetriou E; Verghese J; Holtzer R; Barzilai N; Milman S
Cells; 2020 Jun; 9(6):. PubMed ID: 32492897
[TBL] [Abstract][Full Text] [Related]
9. Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults.
Aneke-Nash CS; Parrinello CM; Rajpathak SN; Rohan TE; Strotmeyer ES; Kritchevsky SB; Psaty BM; Bůžková P; Kizer JR; Newman AB; Strickler HD; Kaplan RC
J Am Geriatr Soc; 2015 May; 63(5):902-9. PubMed ID: 25989565
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
11. The Association Between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study.
Aneke-Nash CS; Xue X; Qi Q; Biggs ML; Cappola A; Kuller L; Pollak M; Psaty BM; Siscovick D; Mukamal K; Strickler HD; Kaplan RC
J Clin Endocrinol Metab; 2017 Dec; 102(12):4541-4547. PubMed ID: 29040592
[TBL] [Abstract][Full Text] [Related]
12. Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 Diabetes.
van Dijk PR; Logtenberg SJ; Chisalita SI; Hedman CA; Groenier KH; Gans RO; Kleefstra N; Arnqvist HJ; Bilo HJ
J Clin Endocrinol Metab; 2016 Jun; 101(6):2493-501. PubMed ID: 27115061
[TBL] [Abstract][Full Text] [Related]
13. Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study.
Kaplan RC; Bùzková P; Cappola AR; Strickler HD; McGinn AP; Mercer LD; Arnold AM; Pollak MN; Newman AB
J Clin Endocrinol Metab; 2012 Jun; 97(6):1970-6. PubMed ID: 22442270
[TBL] [Abstract][Full Text] [Related]
14. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
15. Sleep and insulin-like growth factors in the Cardiovascular Health Study.
Shah N; Rice T; Tracy D; Rohan T; Bůžková P; Newman A; Kaplan RC
J Clin Sleep Med; 2013 Dec; 9(12):1245-51. PubMed ID: 24340285
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A
J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
[TBL] [Abstract][Full Text] [Related]
18. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
[TBL] [Abstract][Full Text] [Related]
19. Serum insulin-like growth factor (IGF)-I and IGF-binding protein-1 in elderly people: relationships with cardiovascular risk factors, body composition, size at birth, and childhood growth.
Kajantie E; Fall CH; Seppälä M; Koistinen R; Dunkel L; Ylihärsilä H; Osmond C; Andersson S; Barker DJ; Forsén T; Holt RI; Phillips DI; Eriksson J
J Clin Endocrinol Metab; 2003 Mar; 88(3):1059-65. PubMed ID: 12629086
[TBL] [Abstract][Full Text] [Related]
20. The effect of growth hormone on the insulin-like growth factor system during fasting.
Nørrelund H; Frystyk J; Jørgensen JO; Møller N; Christiansen JS; Ørskov H; Flyvbjerg A
J Clin Endocrinol Metab; 2003 Jul; 88(7):3292-8. PubMed ID: 12843178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
